Immunotherapy for the treatment of metastatic sarcomatoid kidney cancer
Sarcomatoid renal cell carcinoma (sRCC) is a rare and aggressive form of [...]
First-line treatment of patients with sarcomatoid kidney cancer
Sarcomatoid renal cell carcinoma (sRCC) is a rare and aggressive [...]
Atexolizumab plus bevacizumab for sarcomatoid kidney cancer
A study published in European Urology in July looks at [...]
Diagnostic biomarkers for rare subtype of kidney cancer
There are more than 10 different subtypes of renal cell [...]
Predictive factors for recurrence after complete metastasectomy in metastatic kidney cancer patients
In this retrospective study, published in Science Direct this month, [...]
Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma
In this video interview from Practice Update, Dr Brad McGregor [...]
Atezolizumab and bevacizumab in patients with advanced non-clear cell renal cell carcinoma
Dr Rana McKay from University of California in San Diego, [...]
Sarcomatoid RCC – molecular features and new opportunities for treatment
Sarcomatoid renal cell carcinoma (RCC) is difficult to treat and [...]
Neutrophil-lymphocyte ratio for predicting survival in sarcomatoid kidney cancer
A recent study of 230 patients with sarcomatoid renal cell [...]
Sunitinib and pazopanib for non-clear cell and sarcomatoid kidney cancer
Non-clear cell renal cell carcinoma (RCC) and sarcomatoid renal cell [...]
